XML 48 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Tables)
6 Months Ended
Jun. 29, 2018
Segment Reconciliation [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
 
Three Months Ended
 
Six Months Ended
 
June 29,
2018
 
June 30,
2017
 
June 29,
2018
 
June 30,
2017
Segment sales from continuing operations by product line:
 
 
 
 
 
 
Medical
 
 
 
 
 
 
 
Cardio & Vascular
$
148,766

 
$
130,718

 
$
285,629

 
$
254,202

Cardiac & Neuromodulation
115,941

 
106,173

 
224,851

 
209,928

Advanced Surgical, Orthopedics & Portable Medical
34,751

 
28,282

 
68,692

 
56,433

Total Medical
299,458

 
265,173

 
579,172

 
520,563

Non-Medical
15,006

 
15,743

 
27,718

 
27,089

Total sales from continuing operations
$
314,464

 
$
280,916

 
$
606,890

 
$
547,652

Reconciliation of Operating Profit (Loss) from Segments to Consolidated
 
Three Months Ended
 
Six Months Ended
 
June 29,
2018
 
June 30,
2017
 
June 29,
2018
 
June 30,
2017
Segment income from continuing operations:
 
 
 
 
 
 
 
Medical
$
61,179

 
$
51,557

 
$
108,694

 
$
99,274

Non-Medical
4,393

 
4,940

 
7,591

 
6,502

Total segment income from continuing operations
65,572

 
56,497

 
116,285

 
105,776

Unallocated operating expenses
(21,214
)
 
(20,435
)
 
(41,884
)
 
(45,811
)
Operating income from continuing operations
44,358

 
36,062

 
74,401

 
59,965

Unallocated expenses, net
(12,563
)
 
(26,248
)
 
(24,148
)
 
(46,414
)
Income before taxes from continuing operations
$
31,795

 
$
9,814

 
$
50,253

 
$
13,551